TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 3 | 7 | -4 | -4 | 7 | 0 | 2 |
| P | %wins | 100 | 100 | 50 | 25 | 100 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/16/16 20:23 | 9/14/16 | ADMS | Adamas Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Mdv IX LP | CA | T | P.m | 1,038 | 16.48 | 4 | 63 | 1 | 4,620 | I | -7 | -14 | 36 | 0 | 16 | 27 | 11 | 7 | 1 | 4 | -18 | -12 | 0 | ||
9/14/16 19:02 | 9/12/16 | ADMS | Adamas Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Mdv IX LP | CA | T | P.m | 1,315 | 15.58 | 4 | 84 | 2 | 4,557 | I | -12 | -20 | 19 | -1 | 10 | 11 | 5 | -1 | 3 | 10 | -8 | -5 | 8 | ||
9/9/16 19:25 | 9/7/16 | ADMS | Adamas Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Mdv IX LP | CA | T | P | 954 | 15.68 | 4 | 61 | 1 | 4,472 | I | -10 | -15 | 18 | -5 | 12 | 13 | 23 | 9 | 4 | 11 | 5 | 3 | 12 | ||
9/7/16 20:39 | 9/2/16 | ADMS | Adamas Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Mdv IX LP | CA | T | P.m | 753 | 14.79 | 3 | 51 | 1 | 4,412 | I | -15 | -20 | 9 | -12 | 7 | 8 | 14 | 11 | 3 | 2 | 6 | -1 | 8 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |